Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
Kerstin Menck, Saskia Heinrichs, Cornelia Baden, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 142-142
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Wnt signaling in colorectal cancer: pathogenic role and therapeutic target
Hui Zhao, Tianqi Ming, Shun Tang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 512
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 374
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Meng Zhang, Qian Liu, Hui Meng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 175
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk
Kevin Qin, Michael S. Yu, Jiaming Fan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 103-134
Open Access | Times Cited: 76
Liquid Crystal Monomer: A Potential PPARγ Antagonist
Haoduo Zhao, Caixia Li, Mihir Yogesh Naik, et al.
Environmental Science & Technology (2023) Vol. 57, Iss. 9, pp. 3758-3771
Closed Access | Times Cited: 44
The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities
Michael S. Yu, Kevin Qin, Jiaming Fan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101026-101026
Open Access | Times Cited: 43
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Breast cancer immunotherapy: Current and novel approaches
Khadijeh Barzaman, Shima Moradi‐Kalbolandi, Aysooda Hosseinzadeh, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107886-107886
Closed Access | Times Cited: 81
Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
Yuming Zhao, Dengyang Zhang, Yao Guo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 73
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Parnaz Merikhian, Mohammad Reza Eisavand, Leila Farahmand
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 73
Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
Kinjal Shah, Julhash U. Kazi
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 55
The strategies to cure cancer patients by eradicating cancer stem-like cells
Yansui Mai, Jiyan Su, Chuan Yang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth
Keshan Wang, Fen Ma, Seiji Arai, et al.
Cancer Research (2023) Vol. 83, Iss. 7, pp. 1016-1030
Open Access | Times Cited: 24
WNT5B drives osteosarcoma stemness, chemoresistance and metastasis
Rachel S. Perkins, Glenn Murray, Sarocha Suthon, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 9
WNT Signaling as a Therapeutic Target for Glioblastoma
Michael Latour, Nam-Gu Her, Santosh Kesari, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8428-8428
Open Access | Times Cited: 49
The signaling pathways activated by ROR1 in cancer
María Josefina Quezada, Pablo Lopez‐Bergami
Cellular Signalling (2023) Vol. 104, pp. 110588-110588
Closed Access | Times Cited: 22
PD‐L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD‐L1‐low and ‐negative patients with non‐small cell lung cancer
Nadja Schöne, Marcel Kemper, Kerstin Menck, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 8
Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer
Charlotte Dessaux, Laëtitia Ganier, Louis Guiraud, et al.
Oncogene (2024) Vol. 43, Iss. 26, pp. 1973-1984
Open Access | Times Cited: 7
ROR1-targeting switchable CAR-T cells for cancer therapy
Haiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Oncogene (2022) Vol. 41, Iss. 34, pp. 4104-4114
Open Access | Times Cited: 23
Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 949-949
Open Access | Times Cited: 5
WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer
Kerstin Menck, Saskia Heinrichs, Darius Wlochowitz, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 29
Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition
Dustin J. Flanagan, Simon A. Woodcock, Caroline Phillips, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108179-108179
Open Access | Times Cited: 22
Oncofetal proteins and cancer stem cells
Qian Yan, Xiaona Fang, Chenxi Li, et al.
Essays in Biochemistry (2022) Vol. 66, Iss. 4, pp. 423-433
Closed Access | Times Cited: 19
The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy
Xinlin Liu, Junwen Deng, Renshuai Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions
Min Zheng, Ankush Kumar, Vishakha Sharma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top